Mark James Litton Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark James Litton.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark James Litton. Mark James Litton is a Chief Business Officer in ALDER BIOPHARMACEUTICALS INC ($ALDR) and a Chief Operating Officer in Athira Pharma, Inc. ($ATHA) and a See Remarks in ALPINE IMMUNE SCIENCES, INC. ($ALPN).
Address: 11804 NORTH CREEK PARKWAY SOUTH BOTHELL 98011 WA
Companies in which Mark James Litton is an Insider
ALDER BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark James Litton: Chief Business Officer
Holdings: 124,916 shares
Current Value: $2,898,051
Latest Transaction: Jun 05 2018
$ALDR Market Capitalization: $1.19B
$ALDR Previous Close: $23.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALPINE IMMUNE SCIENCES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark James Litton: See Remarks
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 08 2019
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Athira Pharma, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark James Litton: Chief Operating Officer
Holdings: 63,566 shares
Latest Transaction: Feb 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark James Litton
Sentiment: All, ALDR, ALPN, ATHA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22 2021 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | A | 21.15 | 85,000 | 1,797,750 | 85,000 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 6,563 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 6,563 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 6,563 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 13,126 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 6,563 | 0 | 6,563 | 0 to 6.6 K |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 6,563 | 0 | 6,563 | 0 to 6.6 K |